The potential use of thalidomide in the therapy of graft-versus-host disease--a review of clinical and laboratory information

Leukemia Research
P M Wood, S J Proctor

Abstract

This article reviews the historical development of thalidomide as an immunosuppressive agent and the current state of knowledge of thalidomide as an anti-graft-versus-host disease (GVHD) agent. The evidence suggests that metabolites of thalidomide act at an early stage in the antigen recognition-activation pathway of graft T lymphocytes and down regulate normal lymphocyte responses. This effect seems to have beneficial effects in both acute and chronic GVHD, but the optimal mode of use in the clinical setting remains to be determined.

References

Feb 19, 1966·Lancet·K HELLMANN
Dec 1, 1968·Journal of Neurology, Neurosurgery, and Psychiatry·P M Fullerton, D J O'Sullivan
Apr 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·G B GordonV Balasubramanian
Dec 1, 1958·Proceedings of the Society for Experimental Biology and Medicine·D E UPHOFF
Sep 18, 1965·British Medical Journal·K HELLMANND F TUCKER

Citations

May 29, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H YanoM Kojiro
Jan 13, 2001·Dermatologic Clinics·C L Radomsky, N Levine
Aug 1, 1991·The New England Journal of Medicine·K I Kaitin
Jul 28, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Hassane IzzedineGilbert Deray
Jan 25, 2005·International Journal of Dermatology·Inacio R FaverRokea el-Azhary
Apr 24, 2008·Pediatric Dermatology·Julia P TollandE Ann Bingham
Aug 10, 2005·The British Journal of Dermatology·J J WuS K Tyring
Dec 1, 1996·Journal of the American Academy of Dermatology·S TsengJ L Shupack
Apr 27, 2001·Expert Opinion on Investigational Drugs·D Gaziev, G Lucarelli
Jul 5, 2005·Expert Opinion on Investigational Drugs·L Calabrese, K Resztak
Aug 15, 2003·Leukemia & Lymphoma·Mary E D Flowers, Paul J Martin
Apr 3, 2001·Bone Marrow Transplantation·H SchlossbergK Mangan
Jun 10, 2009·The Journal of Pharmacy and Pharmacology·Sayed H AudaReinhard H H Neubert
Oct 11, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roger K StrairEdmund C Lattime
Dec 22, 1998·Seminars in Cutaneous Medicine and Surgery·D I Stirling

Related Concepts

Acute Disease
Metazoa
Chronic Disease
Graft-vs-Host Disease
Immunosuppressive Agents
Rats, Inbred Lew
T-Lymphocyte
Thalomid
Receptor Down-Regulation
Rats, Laboratory

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.